
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.410 | 1.590 | 0.180 |
Shares | 98.600 | 98.600 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.574 | 17.767 |
Price to Book | 4.034 | 3.804 |
Price to Sales | 4.732 | 5.020 |
Price to Cash Flow | 12.591 | 15.605 |
Dividend Yield | 0.863 | 0.540 |
5 Years Earnings Growth | 7.324 | 13.106 |
Number of long holdings: 98
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 10.81 | 109.02 | -0.28% | |
Amgen | US0311621009 | 8.12 | 287.01 | -0.88% | |
Vertex | US92532F1003 | 7.74 | 445.87 | -0.14% | |
Regeneron Pharma | US75886F1075 | 4.41 | 484.93 | -0.60% | |
Alnylam | US02043Q1076 | 3.29 | 305.18 | +0.46% | |
AstraZeneca ADR | US0463531089 | 3.14 | 73.00 | +1.64% | |
Insmed | US4576693075 | 2.99 | 73.71 | +0.86% | |
Illumina | US4523271090 | 2.20 | 83.16 | +1.63% | |
argenx ADR | US04016X1019 | 2.16 | 573.51 | -0.54% | |
Neurocrine | US64125C1099 | 2.00 | 124.63 | -0.30% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DE000A2DU1Y2 | 16.68M | -0.15 | -3.20 | 1.46 | ||
Kapital Plus P EUR | 7.57M | 0.91 | -2.17 | 2.49 | ||
Kapital Plus P2 EUR | 1.83M | 2.45 | 0.39 | 2.48 | ||
Kapital Plus I EUR | 97.29M | 2.43 | 0.24 | 2.33 | ||
Kapital Plus A EUR | 2.51B | -1.26 | -0.49 | 1.05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review